Ever Fortune.AI Co., Ltd. (6841.TWO)

TWD 71.0

(-2.74%)

Market Cap (In TWD)

6.84 Billion

Revenue (In TWD)

93.98 Million

Net Income (In TWD)

-42.04 Million

Avg. Volume

956 Thousand

Currency
TWD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
70.0-124.0
PE
-
EPS
-
Beta Value
0.829
ISIN
TW0006841000
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Healthcare
CEO
Ming-Fong Chen M.D.
Employee Count
-
Website
https://www.everfortuneai.com.tw
Ipo Date
2021-09-14
Details
Ever Fortune.AI Co., Ltd. provides artificial intelligence cloud services. It offers bone age assessment system that assists doctors in bone age assessment and predicting a child's final height; and breast ultrasound tumor classification system, which assists doctors in the diagnosis of the tumor, non-invasive screening of breast puncture, and biopsy to determine the malignancy of the breast tumor. The company also provides computer tomography liver cancer metastatic risk assessment system that enhances the radiologist's efficiency and assesses the metastatic risk of liver cancer; liver fibrosis assessment system to assess liver fibrosis; and an atrial fibrillation detection system that interprets the electrocardiogram signal and assesses the condition of the heart. Ever Fortune.AI Co., Ltd. is based in Taichung City, Taiwan. Ever Fortune.AI Co., Ltd operates as a subsidiary of An Ji Biomedical Corporation.